ReePrime
3 Point Analysis | UPL Q4FY19 Review

Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.

3 Point Analysis | UPL Q4FY19 Review

M
Moneycontrol

2 Views • May 20, 2019

Description

Post the big ticket acquisition of Arysta lifesciences last year, UPL has reported a subdued set of Q4 results. While the operating performance (excluding Arysta remained healthy), the combined numbers remained impacted. Sakshi Batra does a 3 point analysis of the earnings fine print and the outlook on the company.